Evaluation of Long-Term Outcomes of Direct Acting Antiviral Agents in Chronic Kidney Disease Subjects: A Single Center Cohort Study.
Paulina CzarneckaKinga CzarneckaOlga TroninaTeresa BaczkowskaAleksandra Wyczałkowska-TomasikMagdalena DurlikKatarzyna CzerwinskaPublished in: Journal of clinical medicine (2023)
DAAs provide a safe and effective cure for CHC in both CKD patients and KTRs with a favorable safety profile in the long-term follow-up.